The role of tau in synapse survival and its relevance to Alzheimer’s disease
Status / Stage
ActiveDates
1 September 2019 -31 August 2024
Duration (calculated)
04 years 11 monthsFunder(s)
Alzheimer's Research UKFunding Amount
£499,895.04Funder/Grant study page
Alzheimer's Research UKContracted Centre
University of EdinburghContracted Centre Webpage
Principal Investigator
Dr Claire DurrantPI Contact
claire.durrant@ed.ac.ukPI ORCID
0000-0001-7552-7358WHO Catergories
Models of DiseaseUnderstanding risk factors
Understanding Underlying Disease
Disease Type
Alzheimer's Disease (AD)CPEC Review Info
Reference ID | 221 |
---|---|
Researcher | Reside Team |
Published | 12/06/2023 |
Data
Status / Stage | Active |
---|---|
Start Date | 20190901 |
End Date | 20240831 |
Duration (calculated) | 04 years 11 months |
Funder/Grant study page | Alzheimer's Research UK |
Contracted Centre | University of Edinburgh |
Contracted Centre Webpage | |
Funding Amount | £499,895.04 |
Aims
Investigate the role of tau in keeping synapses – the connections between brain cells – healthy and how this changes in Alzheimer’s disease. The tau protein is an important target for future dementia treatments and understanding more about its role in Alzheimer’s disease will be key for the success of this approach.